1 2 3 4 5

Vaginal Progesterone as Maintenance Treatment After an Episode of Preterm Labour (PROMISE) Study: A Multicentre, Double-blind, Randomised, Placebo-Controlled Trial

Palacio, Montse; Cobo, Teresa; Antolín, Eugenia; More

Obstetrical & Gynecological Survey . 72(3):151-153, March 2017.

Long-term Risk of Endometrial Cancer Following Postmenopausal Bleeding and Reassuring Endometrial Biopsy

Visser, Nicole C. M.; Sparidaens, Ellen Marie; van den Brink, Jan-Willem; More

Obstetrical & Gynecological Survey . 72(3):165-166, March 2017.

Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review

Evans, Elizabeth Casiano; Matteson, Kristen A.; Orejuela, Francisco J.; More

Obstetrical & Gynecological Survey . 72(4):220-221, April 2017.

Word Catheter and Marsupialisation in Women With a Cyst or Abscess of the Bartholin Gland (WoMan-Trial): A Randomised Clinical Trial

Kroese, J. A.; van der Velde, M.; Morssink, L. P.; More

Obstetrical & Gynecological Survey . 72(2):89-90, February 2017.

Vaginal Progesterone Prophylaxis for Preterm Birth (the OPPTIMUM Study): A Multicentre, Randomized, Double-Blind Trial

Norman, Jane Elizabeth; Marlow, Neil; Messow, Claudia-Martina; More

Obstetrical & Gynecological Survey . 71(9):517-518, September 2016.

Vaginal and Laparoscopic Mesh Hysteropexy for Uterovaginal Prolapse: A Parallel Cohort Study

Gutman, Robert E.; Rardin, Charles R.; Sokol, Eric R.; More

Obstetrical & Gynecological Survey . 72(4):225-226, April 2017.

Sensitivity of Fetal RhD Screening for Safe Guidance of Targeted Anti–D Immunoglobulin Prophylaxis: Prospective Cohort Study of a Nationwide Programme in the Netherlands

de Haas, Masja; Thurik, Florentine F.; van der Ploeg, Catharina P. B.; More

Obstetrical & Gynecological Survey . 72(3):155-157, March 2017.

International Standards for Symphysis-Fundal Height Based on Serial Measurements From the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: Prospective Cohort Study...

Papageorghiou, Aris T.; Ohuma, Eric O.; Gravett, Michael G.; More

Obstetrical & Gynecological Survey . 72(3):141-143, March 2017.

Is Mirabegron Equally as Effective When Used as First- or Second-Line Therapy in Women With Overactive Bladder?

Serati, Maurizio; Roberti Maggiore, Umberto Leone; Sorice, Paola; More

Obstetrical & Gynecological Survey . 72(3):160-161, March 2017.

1 2 3 4 5